Roles > Caenorhabditis elegans metabolite
Page last updated: 2024-08-05 14:48:27
Caenorhabditis elegans metabolite
A nematode metabolite produced by Caenorhabditis elegans.
ChEBI ID: 78804
Members (7)
| Member | Definition | Class |
|---|
| 2-aminoadipic acid | An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine. | 2-aminoadipic acid |
| ascr#3 | An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,8R)-8-hydroxynon-2-enoic acid with ascarylopyranose (the alpha anomer). It is a major component of the dauer pheromone, used by the nematode Caenorhabditis elegans as a population-density signal to promote entry into an alternate larval stage, the nonfeeding and highly persistent dauer diapause, and also synergises with ascr#2, ascr#4, and ascr#8 in male attraction. | ascr#3 |
| ascr#5 | An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 3-hydroxypropanoic acid with ascarylopyranose (the alpha anomer). A major component of the dauer pheromone of the nematode Caenorhabditis elegans, it synergises with ascr#2 and ascr#3 as a population-density signal to promote entry into an alternate larval stage, the nonfeeding and highly persistent dauer diapause. | ascr#5 |
| delta7-dafachronic acid | A Delta(7)-dafachronic acid that has S configuration at position 25 (the carbon attached to the carboxy group). | (25S)-Delta(7)-dafachronic acid |
| glycerol 1-stearate | A 1-monoglyceride that has stearoyl as the acyl group. | 1-monostearoylglycerol; rac-1-monostearoylglycerol |
| triolein | A triglyceride formed by esterification of the three hydroxy groups of glycerol with oleic acid. Triolein is one of the two components of Lorenzo's oil. | triolein |
| tristearin | A triglyceride that is glycerol in which all three hydroxy groups have been formally esterified with stearic acid. | tristearoylglycerol |
Research
Studies (2,472)
| Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
|---|
| pre-1990 | 1,148 (46.44) | 18.7374 |
| 1990's | 379 (15.33) | 18.2507 |
| 2000's | 426 (17.23) | 29.6817 |
| 2010's | 444 (17.96) | 24.3611 |
| 2020's | 75 (3.03) | 2.80 |
Study Types
| Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
|---|
| Trials | 42 (1.63%) | 5.53% |
| Reviews | 65 (2.52%) | 6.00% |
| Case Studies | 60 (2.33%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 2,409 (93.52%) | 84.16% |
Protein Targets (14)
Potency Measurements